Search - tctmd.com

Displaying 541 - 560 of 752

Sort: Relevancy | Date

Presentation TCT 2013

Aspirin Dead, Warfarin Still Alive

Presenter: Kristen Patton

October 29, 2013

Presentation TCT 2013

All Novel Agents are Preferred to Warfarin

Presenter: Michael Ezekowitz

October 29, 2013

Presentation TCT 2013

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: Vivek Y. Reddy

October 29, 2013

News Conference News TCT 2013

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

October 29, 2013

News Conference News TCT 2013

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

October 28, 2013

News Conference News TCT 2013

Experts Discuss Efficacy, Safety of Watchman Device

October 28, 2013

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

News Daily News

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

October 04, 2013

News Daily News

Oral Direct Thrombin Inhibitors Linked to Increased MI Risk

L.A. McKeown

October 04, 2013

News Daily News

Los Inhibidores Orales Directos de la Trombina se asocian a un Mayor Riesgo de IM

L.A. McKeown

October 04, 2013

News Daily News

La Troponina T Mejora la Valoración del Riesgo Clínico de sufrir ACV en Pacientes con FA

October 04, 2013

News Daily News

Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin

Jason Kahn

October 04, 2013

News Daily News

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Caitlin E. Cox

October 04, 2013

News Daily News

Consecuencias de Hemorragias Menos Severas en Pacientes a Tratamiento con Dabigatran que en aquellos a Tratamiento con Warfarina

Jason Kahn

October 04, 2013

News Daily News

No Administrar Aspirina Pre-PCI es Causa Habitual de Complicaciones

Caitlin E. Cox

October 04, 2013

Presentation

Management and Outcomes of Major Bleeding During Treatment with Dabigatran or Warfarin

Presenter: A. Majeed

October 03, 2013

Presentation

High Sensitivity Troponin T and Risk Stratification in Patients with A-fib on Apixaban or Warfarin

Presenter: Ziad Hijazi

October 02, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

Presentation ESC 2013

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

Presenter: Alvaro Avezum

September 03, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

Advertisement

Aspirin Dead, Warfarin Still Alive

All Novel Agents are Preferred to Warfarin

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease

Understanding Differences Among New Oral Anticoagulants Should Increase Compliance

Experts Discuss Efficacy, Safety of Watchman Device

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

Oral Direct Thrombin Inhibitors Linked to Increased MI Risk

Los Inhibidores Orales Directos de la Trombina se asocian a un Mayor Riesgo de IM

La Troponina T Mejora la Valoración del Riesgo Clínico de sufrir ACV en Pacientes con FA

Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Consecuencias de Hemorragias Menos Severas en Pacientes a Tratamiento con Dabigatran que en aquellos a Tratamiento con Warfarina

No Administrar Aspirina Pre-PCI es Causa Habitual de Complicaciones

Management and Outcomes of Major Bleeding During Treatment with Dabigatran or Warfarin

High Sensitivity Troponin T and Risk Stratification in Patients with A-fib on Apixaban or Warfarin

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

Apixaban versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Findings from the ARISTOTLE Trial

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content